Linscomb Wealth’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.26M Buy
14,771
+31
+0.2% +$8.58K 0.14% 130
2026
Q1
$4.35M Sell
14,740
-2,701
-15% -$802K 0.19% 99
2025
Q4
$4.76M Buy
17,441
+1,067
+7% +$290K 0.2% 103
2025
Q3
$4.42M Buy
16,374
+1,092
+7% +$297K 0.19% 106
2025
Q2
$4.21M Buy
+15,282
New +$4.16M 0.19% 103
2021
Q1
Sell
-1,112
Closed -$202K 332
2020
Q4
$202K Buy
+1,112
New +$189K 0.01% 306
2014
Q3
Sell
-18,339
Closed -$1.3M 283
2014
Q2
$1.3M Buy
18,339
+3,147
+21% +$222K 0.14% 97
2014
Q1
$1.13M Buy
15,192
+2,032
+15% +$153K 0.12% 102
2013
Q4
$1.03M Buy
13,160
+1,943
+17% +$152K 0.13% 100
2013
Q3
$829K Buy
11,217
+755
+7% +$55.6K 0.11% 104
2013
Q2
$795K Buy
+10,462
New +$686K 0.11% 107

Other funds holding CME

Linscomb Wealth's CME Position: Q2 2026 in Review

Linscomb Wealth increased its CME Group (CME) stake by 0.21% in Q2 2026, buying an estimated $8.58K and bringing the position to 14,771 shares worth $3.26M. The position accounts for 0.14% of the portfolio, ranked #130.

Linscomb Wealth first reported a position in CME in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.76M in Q4 2025. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Linscomb Wealth held 14,771 shares of CME Group worth $3.26M as of Q2 2026.
  • Linscomb Wealth bought 31 CME Group shares in Q2 2026, an estimated $8.58K.
  • CME Group made up 0.14% of Linscomb Wealth's portfolio in Q2 2026, its #130 holding.
  • Linscomb Wealth first reported a position in CME Group in Q2 2013 and has held it in 11 quarters since.
  • Linscomb Wealth's CME Group position peaked at $4.76M in Q4 2025.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Linscomb Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.